Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Augmented Reality, Thoracic Surgery, and Improving the Patient Experience.

JAMA surgery·2026
Same author

Feasibility and oncologic outcomes of minimally invasive surgery after induction chemoimmunotherapy for non-small cell lung cancer.

JTCVS open·2026
Same author

Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Gastroesophageal Adenocarcinoma.

JCO precision oncology·2026
Same author

Utilization of invasive mediastinal nodal staging and prevalence of occult nodal disease in patients with synchronous primary lung cancers.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Overcoming Clinical Blind Spots in Esophageal Cancer.

JAMA surgery·2026
Same author

The role of diagnostic laparoscopy in staging distal esophageal adenocarcinoma.

JTCVS open·2025

Related Experiment Video

Updated: Mar 17, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

300

Lymph Node Dissection and Pulmonary Metastasectomy.

Smita Sihag1, Ashok Muniappan1

  • 1Department of Thoracic Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Blake 1570, Boston, MA 02114, USA.

Thoracic Surgery Clinics
|July 19, 2016
PubMed
Summary

Pulmonary metastasectomy patients have a 20% chance of unexpected lymph node involvement, impacting survival. Understanding patient and tumor factors is key for lymph node assessment during this surgery.

Keywords:
LungLymph nodeMetastasectomy

More Related Videos

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
06:46

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection

Published on: January 9, 2026

287
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
06:09

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

13.7K

Related Experiment Videos

Last Updated: Mar 17, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

300
Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
06:46

Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection

Published on: January 9, 2026

287
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
06:09

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

13.7K

Area of Science:

  • Thoracic Surgery
  • Surgical Oncology
  • Pulmonary Medicine

Background:

  • Lymph node metastasis is a significant prognostic factor in patients with pulmonary metastases.
  • Approximately 20% of patients undergoing pulmonary metastasectomy present with unexpected lymph node involvement.
  • The presence of lymph node metastasis is frequently linked to reduced survival rates.

Purpose of the Study:

  • To review the indications for lymph node assessment during pulmonary metastasectomy.
  • To elucidate the role of lymph node assessment in managing patients with pulmonary metastases.

Main Methods:

  • Literature review of studies on lymph node assessment in pulmonary metastasectomy.
  • Analysis of patient and tumor variables associated with lymph node involvement.
  • Review of survival data in relation to lymph node status.

Main Results:

  • Lymph node involvement occurs in about 20% of cases undergoing pulmonary metastasectomy.
  • Patient and tumor characteristics influence the likelihood of lymph node metastasis.
  • Lymph node metastasis is associated with poorer outcomes.

Conclusions:

  • Lymph node assessment is crucial in pulmonary metastasectomy due to its impact on survival.
  • Identifying factors predicting lymph node involvement can guide surgical decision-making.
  • Further research into optimal lymph node staging strategies is warranted.